Johnson & Johnson (NYSE:JNJ) has secured Chinese approval for Icotyde, its once-daily oral treatment for moderate-to-severe ...

Novo Nordisk A/S (NYSE:NVO) has moved one step closer to bringing its oral Wegovy treatment to China after the country’s drug ...

During the Mad Money episode aired on 8, Jim Cramer designated Palantir Technologies (NASDAQ:PLTR) as a portfolio wide ...

Performance within the M&D segment was driven by strong technology market trends, with further support coming from ABM’s ...

The deal would therefore enable GE to control the constraint as well as defend its margins. CEO Larry Culp characterized the ...

Daktronics Inc. (NASDAQ:DAKT) reported its Q1 FY27 results, showing continued momentum across core segments and its strategic ...

On 8, ServiceTitan, Inc. (NASDAQ:TTAN) reported its fiscal second-quarter financial results, which showed impressive growth.

The pharmaceutical sector was hit with major pipeline news on September 1 when Novartis AG (NYSE:NVS) paused eight clinical ...

While CrowdStrike Holdings, Inc. wins on financial maturity and cash generation, Rubrik, Inc. offers faster percentage ...

Cisco Systems, Inc. (NASDAQ:CSCO), and Humain announced that their joint AI infrastructure buildout in Saudi Arabia is ...

Both pharmaceutical giants delivered solid Q2 2026 results, but AstraZeneca is showing stronger overall financial momentum.

On 2, Shell Offshore, a subsidiary of Shell plc (NYSE:SHEL), announced the acquisition of a 30% working interest in Conifer, ...